All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Hormonal comparison

Insulin Glargine (Lantus) vs Insulin Lispro (Humalog)

An educational, source-based comparison of Insulin Glargine (Lantus) and Insulin Lispro (Humalog) — how each peptide works, what it's researched for, and what to know before going deeper.

Insulin Analog · Endocrine
Insulin Glargine (Lantus)

Long-acting basal insulin analog for type 1 and type 2 diabetes.

Mechanism

Recombinant human insulin analog with two arginine residues added to the B-chain and asparagine→glycine at A21, forming microprecipitates at injection site for ~24-hour glucose-lowering activity via insulin receptor activation.

Research areas
  • Type 1 diabetes basal coverage
  • Type 2 diabetes basal insulin therapy
  • Gestational diabetes
Considerations
  • FDA-approved.
  • Hypoglycemia and weight gain are primary risks.
  • Do not mix with other insulins.
Full Insulin Glargine (Lantus) profile →
Insulin Analog · Endocrine
Insulin Lispro (Humalog)

Rapid-acting mealtime insulin analog.

Mechanism

Recombinant insulin analog with reversed lysine and proline at B28/B29, reducing self-association so it acts within ~15 minutes for postprandial glucose control.

Research areas
  • Prandial coverage in T1D/T2D
  • Insulin pump therapy
  • Hyperglycemic crises (with caution)
Considerations
  • FDA-approved.
  • Hypoglycemia risk if meal delayed or skipped.
Full Insulin Lispro (Humalog) profile →

Insulin Glargine (Lantus) vs Insulin Lispro (Humalog) — Key differences

  • Class: Insulin Glargine (Lantus) is classified as Insulin Analog · Endocrine, while Insulin Lispro (Humalog) is Insulin Analog · Endocrine.
  • Primary research focus: Insulin Glargine (Lantus)type 1 diabetes basal coverage; Insulin Lispro (Humalog)prandial coverage in t1d/t2d.
  • Tag: FDA-Approved · Diabetes vs FDA-Approved · Diabetes.

Related comparisons